Total number of protein in "GO:2000311" GO term: 23
Identifier |
UniProt Gene |
UniProt Accession |
UniProt Name |
Chromosome |
GO term |
Database |
Cancer Driver |
Number of missense mutations |
Missense mutation per residues |
Number of disordered residues |
Number of mutations in disordered regions |
Disordered missense mutations per residues |
Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADRB2 | ADRB2 | P07550 | Beta-2 adrenergic receptor | chr5 | GO:2000311 | Not Cancer Driver | No | 52 | 0.126 | 35 | 4 | 0.114 | 0 |
ARC | ARC | Q7LC44 | Activity-regulated cytoskeleton-associated protein | chr8 | GO:2000311 | Not Cancer Driver | No | 64 | 0.162 | 194 | 29 | 0.149 | 0 |
CACNG2 | CACNG2 | Q9Y698 | Voltage-dependent calcium channel gamma-2 subunit | chr22 | GO:2000311 | Not Cancer Driver | No | 57 | 0.176 | 90 | 16 | 0.178 | 1 |
CACNG3 | CACNG3 | O60359 | Voltage-dependent calcium channel gamma-3 subunit | chr16 | GO:2000311 | Not Cancer Driver | No | 126 | 0.4 | 69 | 37 | 0.536 | 0 |
CACNG4 | CACNG4 | Q9UBN1 | Voltage-dependent calcium channel gamma-4 subunit | chr17 | GO:2000311 | Not Cancer Driver | No | 51 | 0.156 | 71 | 17 | 0.239 | 0 |
CACNG5_ENST00000307139 | CACNG5 | Q9UF02 | Voltage-dependent calcium channel gamma-5 subunit | chr17 | GO:2000311 | Not Cancer Driver | No | 77 | 0.28 | 1 | 0 | 0.0 | 0 |
CACNG7 | CACNG7 | P62955 | Voltage-dependent calcium channel gamma-7 subunit | chr19 | GO:2000311 | Not Cancer Driver | No | 99 | 0.36 | 9 | 1 | 0.111 | 0 |
CACNG8 | CACNG8 | Q8WXS5 | Voltage-dependent calcium channel gamma-8 subunit | chr19 | GO:2000311 | Not Cancer Driver | No | 47 | 0.111 | 205 | 15 | 0.073 | 0 |
CNIH2 | CNIH2 | Q6PI25 | Protein cornichon homolog 2 | chr11 | GO:2000311 | Not Cancer Driver | No | 20 | 0.125 | 0 | 0 | 0.0 | 0 |
CNIH3 | CNIH3 | Q8TBE1 | Protein cornichon homolog 3 | chr1 | GO:2000311 | Not Cancer Driver | No | 27 | 0.169 | 0 | 0 | 0.0 | 0 |
GSG1L | GSG1L | Q6UXU4 | Germ cell-specific gene 1-like protein | chr16 | GO:2000311 | Not Cancer Driver | No | 55 | 0.166 | 42 | 7 | 0.167 | 0 |
MAPK8IP2 | MAPK8IP2 | Q13387 | C-Jun-amino-terminal kinase-interacting protein 2 | chr22 | GO:2000311 | Not Cancer Driver | No | 49 | 0.059 | 568 | 27 | 0.048 | 0 |
MEF2C_ENST00000504921 | MEF2C | Q06413 | Myocyte-specific enhancer factor 2C | chr5 | GO:2000311 | Not Cancer Driver | No | 92 | 0.195 | 408 | 81 | 0.199 | 0 |
MINK1 | MINK1 | Q8N4C8 | Misshapen-like kinase 1 | chr17 | GO:2000311 | Not Cancer Driver | No | 113 | 0.085 | 740 | 56 | 0.076 | 0 |
NLGN1_ENST00000361589 | NLGN1 | Q8N2Q7 | Neuroligin-1 | chr3 | GO:2000311 | Not Cancer Driver | No | 214 | 0.248 | 248 | 61 | 0.246 | 4 |
NLGN2 | NLGN2 | Q8NFZ4 | Neuroligin-2 | chr17 | GO:2000311 | Not Cancer Driver | No | 91 | 0.109 | 300 | 19 | 0.063 | 0 |
NLGN3 | NLGN3 | Q9NZ94 | Neuroligin-3 | chrX | GO:2000311 | Not Cancer Driver | No | 158 | 0.186 | 257 | 54 | 0.21 | 2 |
PRRT1 | PRRT1 | Q99946 | Proline-rich transmembrane protein 1 | chr6 | GO:2000311 | Not Cancer Driver | No | 36 | 0.118 | 190 | 19 | 0.1 | 0 |
RELN | RELN | P78509 | Reelin | chr7 | GO:2000311 | Not Cancer Driver | No | 761 | 0.22 | 107 | 19 | 0.178 | 7 |
SHANK1 | SHANK1 | Q9Y566 | SH3 and multiple ankyrin repeat domains protein 1 | chr19 | GO:2000311 | Not Cancer Driver | No | 288 | 0.133 | 1659 | 186 | 0.112 | 0 |
SHISA6_ENST00000409168 | SHISA6 | Q6ZSJ9 | Protein shisa-6 | chr17 | GO:2000311 | Not Cancer Driver | No | 29 | 0.058 | 330 | 22 | 0.067 | 0 |
SHISA7 | SHISA7 | A6NL88 | Protein shisa-7 | chr19 | GO:2000311 | Not Cancer Driver | No | 13 | 0.024 | 429 | 12 | 0.028 | 0 |
SHISA9 | SHISA9 | B4DS77 | Protein shisa-9 | chr16 | GO:2000311 | Not Cancer Driver | No | 28 | 0.066 | 285 | 23 | 0.081 | 0 |
Identifier |
UniProt Gene |
UniProt Accession |
UniProt Name |
Chromosome |
GO term |
Database |
Cancer Driver |
Number of missense mutations |
Missense mutation per residues |
Number of disordered residues |
Number of mutations in disordered regions |
Disordered missense mutations per residues |
Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|